8-K: Evolv Technologies Reports Strong Q1 2026 Results, Raises Outlook

Evolv Technologies announced first quarter 2026 financial results, showcasing significant revenue growth and an improved Adjusted EBITDA, leading to an optimistic revised outlook for the full year 2026.

Summary

• Evolv Technologies reported first quarter 2026 revenue of $46.3 million, a 45% increase year-over-year.
• Annual Recurring Revenue (ARR) grew 20% year-over-year to $127.3 million.
• The net loss for the quarter was $5.0 million, or $(0.03) per share.
• Adjusted EBITDA was $3.9 million, a significant improvement from $2.1 million in the prior year's quarter.
• The company raised its full-year 2026 revenue outlook to $175-$180 million and expects positive full-year Adjusted EBITDA.
• Cash, cash equivalents, and marketable securities stood at $61.1 million as of March 31, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report due to strong revenue growth, improved profitability metrics (Adjusted EBITDA), and an upgraded full-year outlook, despite a continued net loss.

Positives

• Revenue increased by 45% year-over-year to $46.3 million in Q1 2026.
• Annual Recurring Revenue (ARR) grew by 20% year-over-year to $127.3 million.
• Adjusted EBITDA improved to $3.9 million in Q1 2026, up from $2.1 million in Q1 2025.
• Adjusted EBITDA margin increased to 8.5% from 6.4% in the prior year.
• Full-year 2026 revenue outlook raised to $175-$180 million, representing 20%-23% growth.
• Full-year 2026 outlook for ending ARR is projected at $145-$150 million, a 20%-25% increase.
• The company expects to deliver positive full-year Adjusted EBITDA in 2026 with high single-digit margins.
• Non-recurring revenue saw a substantial increase of 142% year-over-year.

Negatives

• Net loss for the first quarter of 2026 was $5.0 million, compared to a net loss of $1.7 million in the prior year.
• Net loss per diluted share was $(0.03) in Q1 2026, compared to $(0.01) in Q1 2025.
• Adjusted loss for the quarter was $(3.3) million, a slight increase from $(3.4) million in Q1 2025.
• Gross margin decreased to 50.9% in Q1 2026 from 59.8% in Q1 2025.

Risks

• The company has a history of losses and its ability to reach profitability remains a concern.
• Reliance on reseller partners for business operations.
• The company recognizes a substantial portion of its revenue ratably over the term of its agreements, meaning downturns or upturns in sales may not be immediately reflected in operating results.
• The rate of innovation required to maintain competitiveness in the markets.
• Failure of products to detect threats could result in injury or loss of life, harming brand and reputation.
• Potential loss of designation as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act.
• Business model predicated on building a customer base for recurring subscription revenues.
• Risks related to material weaknesses in internal control over financial reporting and remediation efforts.

Future Outlook

The company raised its full-year 2026 outlook, expecting total revenues between $175 to $180 million (20%-23% growth) and ending ARR at December 31, 2026, to be approximately $145 to $150 million (20%-25% growth). Evolv Technology anticipates delivering positive full-year Adjusted EBITDA in 2026 with margins in the high single digits.

Management Comments

• "Our first quarter results reflect our progress in building a disciplined and predictable business."
• "Revenue growth during the quarter was driven by new customer acquisition, expanding deployments within our installed base, and growing adoption of our newest product Evolv eXpedite."
• "Looking ahead, we remain focused on scaling the business and delivering weapon screening in complex, real-world environments across the growing customer base we are serving helping make the world a better place to live, learn, work, and play."

Industry Context

StockSavvy.ai notes that Evolv Technologies' strong revenue growth and improved Adjusted EBITDA in Q1 2026, coupled with a raised full-year outlook, indicate positive momentum in the AI-based security screening market. The company's focus on expanding deployments and new product adoption aligns with industry trends towards more sophisticated and integrated security solutions.

Comparison to Industry Standards

• Evolv Technologies' Q1 2026 revenue growth of 45% significantly outpaces the typical growth rates seen in the broader industrial technology sector, which often hovers in the low to mid-single digits.
• The company's Adjusted EBITDA margin of 8.5% is a positive development, though it remains lower than established, mature players in adjacent security markets who may achieve double-digit or higher margins.
• The 20% year-over-year ARR growth is robust, reflecting strong customer retention and acquisition, a key metric for subscription-based business models that is often a focus for investors in SaaS and recurring revenue companies.
• The company's focus on AI-powered screening is a key differentiator, positioning it within a high-growth segment of the security technology market, which is seeing increased investment and innovation from competitors like Genetec and Verkada, though direct comparisons on specific metrics are challenging due to differing business models and reporting.

Legal Proceedings

• The company mentions ongoing securities litigation and related SEC and Department of Justice matters in its forward-looking statements, including potential insurance reimbursements for defense costs.

Stakeholder Impact

• Shareholders: Positive impact from raised outlook and improved financial performance metrics, potentially leading to increased stock value.
• Employees: Continued focus on scaling and growth may lead to new opportunities, but the company's history of losses and ongoing restructuring costs could create uncertainty.
• Customers: Continued development and adoption of AI-based screening solutions aim to enhance safety and user experience in various venues.
• Suppliers: Increased revenue and deployment activity may lead to higher demand for manufacturing and distribution services.

Next Steps

• Continue scaling the business.
• Deliver weapon screening in complex, real-world environments.
• Focus on new customer acquisition and expanding deployments within the installed base.
• Grow adoption of the Evolv eXpedite product.

Key Dates

Recommendation

The company shows strong top-line growth and improved operational profitability (Adjusted EBITDA), along with a raised outlook. However, the continued net loss, declining gross margin, and significant risks outlined in the filing warrant a cautious approach. A 'hold' recommendation reflects the positive momentum balanced against ongoing financial challenges and inherent industry risks.

Keywords

Evolv Technologies, 8-K, Financial Results, Q1 2026, Revenue Growth, Adjusted EBITDA, Security Technology, AI Screening